|
Atkinson
B, Chamberlain J, Logue C H, Cook N, Bruce C, Dowall S D, Hewson R. 2012.
Development of a real-time RT-PCR assay for the detection of Crimean-Congo
hemorrhagic fever virus. Vector Borne and Zoonotic Diseases, 12, 786–793.
Bente D A,
Forrester N L, Watts D M, McAuley A J, Whitehouse C A, Bray M. 2013.
Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical
syndrome and genetic diversity. Antiviral Research, 100,
159–189.
Brinkmann
A, Ergunay K, Radonic A, Kocak Tufan Z, Domingo C, Nitsche A. 2017. Development
and preliminary evaluation of a multiplexed amplification and next generation
sequencing method for viral hemorrhagic fever diagnostics. PLoS Neglected Tropical Diseases, 11, e0006075.
Cao Z,
Wang H, Wang L, Li L, Jin H, Xu C, Feng N, Wang J, Li Q, Zhao Y, Wang T, Gao Y,
Lu Y, Yang S, Xia X. 2016. Visual detection of west nile virus using reverse
transcription loop-mediated isothermal amplification combined with a vertical
flow visualization strip. Frontiers in Microbiology, 7,
554.
Ceylan B,
Calica A, Ak O, Akkoyunlu Y, Turhan V. 2013. Ribavirin is not effective against
Crimean-Congo hemorrhagic fever: Observations from the Turkish experience. International Journal of Infectious Diseases, 17,
E799–E801.
Dai S,
Deng F, Wang H, Ning Y. 2021. Crimean-Congo hemorrhagic fever virus: Current
advances and future prospects of antiviral strategies. Viruses, 13,
1195.
Filippone
C, Marianneau P, Murri S, Mollard N, Avsic-Zupanc T, Chinikar S, Despres P,
Caro V, Gessain A, Berthet N, Tordo N. 2013. Molecular diagnostic and genetic
characterization of highly pathogenic viruses: Application during Crimean-Congo
haemorrhagic fever virus outbreaks in Eastern Europe and the Middle East. Clinical Microbiology and Infection, 19, E118–E128.
Guo R,
Shen S, Zhang Y, Shi J, Su Z, Liu D, Liu J, Yang J, Wang Q, Hu Z, Zhang Y, Deng
F. 2017. A new strain of Crimean-Congo hemorrhagic fever virus isolated from
Xinjiang, China. Virologica Sinica, 32, 80–88.
Kaya S, Elaldi
N, Kubar A, Gursoy N, Yilmaz M, Karakus G, Gunes T, Polat Z, Gozel M G, Engin
A, Dokmetas I, Bakir M, Yilmaz N, Sencan M. 2014. Sequential determination of
serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10,
and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. BMC Infectious Diseases, 14, 416.
Kuehnert P
A, Stefan C P, Badger C V, Ricks K M. 2021. Crimean-Congo hemorrhagic fever
virus (CCHFV): A silent but widespread threat. Current Tropical Medicine
Reports, 8, 141–147.
Lorenzo
Juanes H M, Carbonell C, Sendra B F, Lopez-Bernus A, Bahamonde A, Orfao A,
Lista C V, Ledesma M S, Negredo A I, Rodriguez-Alonso B, Bua B R, Sanchez-Seco
M P, Munoz Bellido J L, Muro A, Belhassen-Garcia M. 2023. Crimean-Congo hemorrhagic
fever, Spain, 2013–2021. Emerging Infectious Diseases, 29,
252–259.
Mazzola L
T, Kelly-Cirino C. 2019. Diagnostic tests for Crimean-Congo haemorrhagic fever:
A widespread tickborne disease. British Medical Journal Global Health, 4,
e001114.
Spengler J
R, Estrada-Pena A, Garrison A R, Schmaljohn C, Spiropoulou C F, Bergeron E,
Bente D A. 2016. A chronological review of experimental infection studies of
the role of wild animals and livestock in the maintenance and transmission of
Crimean-Congo hemorrhagic fever virus. Antiviral Research, 135,
31–47.
Vanhomwegen
J, Alves M J, Zupanc T A, Bino S, Chinikar S, Karlberg H, Korukluoglu G, Korva
M, Mardani M, Mirazimi A, Mousavi M, Papa A, Saksida A, Sharifi-Mood B, Sidira
P, Tsergouli K, Wolfel R, Zeller H, Dubois P. 2012. Diagnostic assays for
Crimean-Congo hemorrhagic fever. Emerging Infectious Diseases, 18, 1958–1965.
Weidmann
M, Avsic-Zupanc T, Bino S, Bouloy M, Burt F, Chinikar S, Christova I, Dedushaj
I, El-Sanousi A, Elaldi N, Hewson R, Hufert F T, Humolli I, Jansen van Vuren P,
Kocak Tufan Z, Korukluoglu G, Lyssen P, Mirazimi A, Neyts J, Niedrig M, et al. 2016. Biosafety standards for working with Crimean-Congo hemorrhagic fever
virus. Journal of General Virology, 97,
2799–2808.
WHO (World
Health Organization). 2015. Prioritizing diseases for research and development
in emergency contexts. [2015-12-9]. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
WHO (World
Health Organization). 2018. Crimean-Congo haemorrhagic fever (CCHF) R&D
roadmap. [2018-6-5]. https://www.who.int/news-room/articles-detail/crimean-congo-haemorrhagic-fever-(cchf)-r-d-roadmap
Wu X, Liu
Y, Gao L, Yan Z, Zhao Q, Chen F, Xie Q, Zhang X. 2022. Development and
application of a reverse-transcription recombinase-aided amplification assay
for porcine epidemic diarrhea virus. Viruses, 14, doi:
10.3390/v14030591.
Yang H,
Wang Y, Yang Q, Fan H, Wang L, Zhang T, Li Z, Liu G, Zhao P, Wu H, Dong J,
Liang W. 2021. A rapid and sensitive detection method for pseudomonas
aeruginosa using visualized recombinase polymerase amplification and lateral
flow strip technology. Frontiers in Cellular and Infection Microbiology, 11, 698929.
Yousaf M
Z, Usman A, Anjum K M, Fatima S. 2018. Crimean-Congo hemorrhagic fever (CCHF)
in Pakistan: The “bell” is ringing silently. Critical Reviews in Eukaryotic Gene Expression, 28, 93–100.
|
